Login / Signup

A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol.

Milagros Gonzalez-RiveraAntoni C PicornellEnrique L ÁlvarezMiguel Martin
Published in: JMIR research protocols (2016)
ClinicalTrials.gov NCT02626039; https://clinicaltrials.gov/ct2/show/NCT02626039 (Archived by WebCite at http://www.webcitation.org/6jlneVyoz).
Keyphrases